Plus, news about Celldex and Pfizer: 📉 Lipocine’s Phase 3 fail: The Utah biotech’s stock {$LPCN} fell 77% after it said its oral brexanolone drug, called LPCN 1154, didn’t show …
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
The organization is matching every dollar up to $50,000 to Build a School in Leprosy-affected Communities in India PLEASANT GROVE, Utah, Dec. 2, 2024 /PRNewswire/ — This Giving Tuesday, dōTERRA Healing Hands Foundation® has partnered […]
SPRINGVILLE, Utah, April 2, 2025 /PRNewswire/ — Sisel International, a leader in science-based nutrition and wellness, has announced a strategic partnership with Gazpro Foundation to expand global nutrition efforts. This collaboration will focus on enhancing […]
PARK CITY, Utah, April 11, 2023 /PRNewswire/ — MRP.io (“MRP”), the first end-to-end marketplace for new and used aesthetics equipment, supplies, and services, announces the attendance at the upcoming 42nd Annual Conference of the American […]
Copyright © 2026 Biotech Networks
